ENDOGEN ApS: Financial statements 2021
CVR: 29813337
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -23,164 and a net result of DKK -24,464 compared with DKK -18,432 the year before. Equity amounted to DKK 54,374. The solvency ratio was 61.2%. The company had 1 employee in the financial year.
- Gross Profit
- -23,164 kr.
- Profit/Loss
- -24,464 kr.
- Equity
- 54,374 kr.
- Total Assets
- 88,852 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -23 t. | -24 t. | 54 t. | 1 |
| 2020 | - | -18 t. | -18 t. | 79 t. | 1 |
| 2019 | - | -48 t. | -49 t. | 97 t. | 1 |
| 2018 | - | -26 t. | -26 t. | 83 t. | 1 |
| 2017 | 0 | -7 t. | -7 t. | 36 t. | - |
Find more companies like ENDOGEN ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
ENDOGEN ApS has published its annual report for 2020. Gross profit came to DKK -18,293, and the net result was DKK -18,432.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity amounted to DKK -82,428.
